Infectious Disease Medical Billing and Coding Services

Support may include coding review, charge entry, claim scrubbing, claim submission, rejection clearing, denial analysis, appeals, eligibility verification, prior authorization, payment reconciliation, aging A/R follow-up, and revenue-cycle workflow review. Infectious disease billing often spans E/M services, hospital consults, infusion administration, drug claims, specialty therapies, and OPAT-related work, so the right support should account for the full revenue cycle.

Infectious disease practices may manage cognitive services alongside infusion, OPAT, drug acquisition, specialty therapies, and payer-specific coverage requirements. Claims can involve distinctions between medical and pharmacy benefits, authorization requirements, administration coding, clinical documentation, and drug units or identifiers. A billing approach that considers only office visits may miss operational and financial issues affecting the broader practice.

Denial reduction starts with identifying root causes rather than treating every denial as an isolated event. Common review areas include documentation, drug and administration coding, authorization, medical-versus-pharmacy benefit handling, and payer-specific requirements. Categorizing denials and sharing findings with clinical, coding, and front-office teams can help address recurring workflow problems and improve future claim submission.

Revenue-cycle consulting can review the path from referral to final payment, including documentation, coding, eligibility, prior authorization, drug and infusion billing, denials, underpayments, A/R follow-up, and payer or hospital coverage agreements. The purpose is to identify where revenue is delayed, lost, or left uncollected, connect each gap to its likely cause, and create a practical priority list for improvement.

Yes. The service catalog includes support related to infusion and OPAT workflows, including eligibility and benefits review, prior authorization, drug and administration claims, payment reconciliation, denial analysis, and revenue-cycle review. Because coverage and billing requirements can vary by therapy, payer, and benefit type, practices should evaluate documentation, authorization, coding, and reimbursement together rather than treating each issue separately.

Payment reconciliation compares payments with expected reimbursement for drug, administration, and E/M claims. The review can identify short-pays, incorrect fee schedule application, and unit or NDC mismatches. Findings may then be disputed and tracked through recovery. This process also helps practices see whether payment problems are isolated claim issues or part of a broader payer or workflow pattern.

A/R support can organize aging claims by payer, service type, and balance, with particular attention to drug, infusion, hospital consult, and complex outpatient claims. Follow-up should document each contact and track the claim until resolution. Reporting the reasons claims stalled can also help the practice address recurring problems in documentation, submission, payer handling, or internal workflow.

The resources are designed for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. They are intended to help users understand financial mechanics, evaluate revenue streams, consider operational decisions, and examine practice sustainability. Users can apply their own figures and circumstances rather than relying on generalized rates, margins, or unsupported benchmarks.